While dealing with a suit filed by Dabur India against commercial advertisements of Patanjali Ayurved allegedly disparaging its Chyawanprash product, the Delhi High Court has ruled that consumer must not be misled to believe in false efficacy or superiority of a regulated drug in the name of commercial freedom of speech.Justice Mini Pushkarna said that advertisers cannot be permitted to...